B. Larrivée

Molecular Biology · 2017

A researcher in the Science corpus: 1 paper; trusts 6 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom B. Larrivée trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain
  2. Peter Carmeliet
  3. G. Bergers

Papers from B. Larrivée's perspective

Ordered by how strongly the researchers B. Larrivée trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
  3. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. (Cancer Research)
  4. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
  5. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. (American Journal of Pathology)
  6. Molecular mechanisms and clinical applications of angiogenesis (Nature)
  7. Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system (Nature reviews. Molecular cell biology)
  8. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. (Cell)
  9. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. (Cancer Cell)
  10. The biology of VEGF and its receptors (Nature Medicine)

Their papers